These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2165451)

  • 1. Effects of PGE1 on platelet deformability.
    Chang YN; Hsu HT; Hung MS; Chang CL; Li JG; Wang DL
    Chin J Physiol; 1990; 33(1):31-40. PubMed ID: 2165451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E1 and dibutyryl cyclic AMP enhance platelet resistance to deformation.
    Wang DL; Chang YN; Hsu HT; Usami S; Chien S
    Thromb Res; 1992 Mar; 65(6):757-68. PubMed ID: 1321994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.
    Palma-Barqueros V; Torregrosa JM; Caparrós-Pérez E; Mota-Pérez N; Bohdan N; Llanos MDC; Begonja AJ; Sola-Visner M; Vicente V; Teruel-Montoya R; Rivera J; Ferrer-Marín F
    Neonatology; 2020; 117(1):15-23. PubMed ID: 31786577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine: possible role of platelet insensitivity to prostaglandin E1 (PGE1).
    Cerneca F; de Luyk S; Radillo O; Simeone R; Mangiarotti M
    Funct Neurol; 1993; 8(6):403-8. PubMed ID: 8150318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1.
    Chirkov YY; Chirkova LP; Sage RE; Horowitz JD
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):961-6. PubMed ID: 7564342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of prostaglandin E1 during preparation of platelet concentrates.
    Hawker RJ; Turner VS; Mitchell SG
    Transfus Med; 1996 Sep; 6(3):249-54. PubMed ID: 8885155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
    J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC; Guccione MA; Packham MA; Mustard JF
    Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
    Khanna V; Armstrong PC; Warner TD; Curzen N
    Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased platelet reactivity to prostaglandin E1 in hypertension is linked with altered signal transduction.
    Huzoor-Akbar ; Dean T; Kornhauser R
    Am J Hypertens; 1993 Oct; 6(10):857-62. PubMed ID: 7505593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
    Kikura M; Kazama T; Ikeda T; Sato S
    Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery and survival in vivo of platelet concentrates prepared with prostaglandin E1.
    Menitove JE; Kagen LR; Aster RH
    Transfusion; 1988; 28(1):56-8. PubMed ID: 3341067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP.
    Oda A; Druker BJ; Smith M; Salzman EW
    Am J Physiol; 1992 Mar; 262(3 Pt 1):C701-7. PubMed ID: 1372480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of parenteral lipid emulsion-induced hyperlipidemia on prostaglandin E1 modulation of platelet function.
    Saladino CF; Kosacolsky-Singer C; Fox R; Nethala V; Feffer SE; Jonas EA
    Artery; 1993; 20(6):303-13. PubMed ID: 8010886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
    Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.
    Jap TS; Kwok CF; Wong MC; Chiang H
    Diabetes Res; 1994; 27(1):39-46. PubMed ID: 7648795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.